IMR Press / CEOG / Volume 40 / Issue 4 / pii/1630389108149-802497522

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Prevention of first-trimester miscarriage with dextroamphetamine sulfate treatment in women with recurrent miscarriage following embryo transfer - case report
Show Less
1 The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden Cooper Hospital/University Medical Center, Department of Obstetrics and Gynecology Division of Reproductive Endocrinology & Infertility, Camden, NJ (USA)
Clin. Exp. Obstet. Gynecol. 2013, 40(4), 471–472;
Published: 10 December 2013

Purpose: To present a novel approach to prevent miscarriage by treatment with sympathomimetic amines. Materials and Methods: Two women undergoing in vitro fertilization-embryo transfer (IVF-ET) with a history of recurrent miscarriage even in IVF-ET cycles were treated with dextroamphetamine sulfate prior to their next IVF-ET cycles. Results: Both women successfully completed their first trimester. One woman delivered a live baby and one had neonatal death related to prematurity secondary to severe pre-eclampsia. Conclusions: Sympathomimetic amines therapy may prove to be an effective therapy to prevent recurrent miscarriage especially in women who have failed despite progesterone therapy, and where no other etiologic factors have been determined.
Embryo transfer
Sympathomimetic amines
Recurrent miscarriage
Dextroamphetamine sulfate
Back to top